Urinary enzyme excretion during treatment of malignancies with human recombinant alpha-2 interferon

Nephrol Dial Transplant. 1987;2(6):515-9.
No abstract available

MeSH terms

  • Acetylglucosaminidase / urine*
  • Adult
  • Female
  • Galactosidases / urine*
  • Hexosaminidases / urine*
  • Humans
  • Interferon Type I / therapeutic use*
  • Interferon Type I / toxicity
  • Kidney / drug effects
  • L-Lactate Dehydrogenase / urine*
  • Leucyl Aminopeptidase / urine*
  • Leukemia, Myeloid / therapy*
  • Lymphoma, Non-Hodgkin / therapy*
  • Male
  • Neoplasms / therapy*
  • Recombinant Proteins / therapeutic use*
  • beta-Galactosidase / urine*
  • gamma-Glutamyltransferase / urine*

Substances

  • Interferon Type I
  • Recombinant Proteins
  • L-Lactate Dehydrogenase
  • gamma-Glutamyltransferase
  • Galactosidases
  • Hexosaminidases
  • beta-Galactosidase
  • Acetylglucosaminidase
  • Leucyl Aminopeptidase